RESEARCH PAPER
Takayasu’s arteritis: a rare disease in Poland
 
More details
Hide details
1
Department of Social Medicine and Public Health, Medical University, Warsaw, Poland
2
Institute of Rural Health, Lublin, Poland
3
National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
4
Department of Gynecological Endocrinology, Clinical Hospital of Duchess Anna Mazowiecka, Medical University, Warsaw, Poland
 
Ann Agric Environ Med. 2018;25(3):469–472
KEYWORDS:
TOPICS:
ABSTRACT:
Introduction:
Takayasu’s arteritis (TA) is a rare and potentially life-threatening granulomatous large-vessel vasculitis that involves mostly in the aorta and its proximal branches, and occurs most commonly in young females. This study measures the incidence and prevalence of TA, and assesses the gender distribution and territorial differences in the occurrences of this disease in Poland over a five-year period. To the best of our knowledge, this is the first evaluation of this rare disease in Poland based on a hospital morbidity database.

Material and methods:
Analyses were performed with population-based administrative data obtained from a national hospital morbidity study carried out between January 2011 – December 2015 by the Polish National Institute of Public Health. Yearly incidence rates and prevalence of TA were calculated using the number of TA patients and corresponding census data for the overall Polish population.

Results:
Data included 660 hospitalization records. The final study sample comprised 177 patients: 154 female (87%) and 23 male (13%) with first-time hospitalization for TA. The mean age was 45.4years (95% CI: 42.9–47.8; SD 16.8; range 4–81 years), median 47. The incidence rate of TA was estimated at 0.92 per million per year (95% CI: 0.68–1.16). Five-year TA prevalence was estimated to be 4,6 per million. Incidence rates of TA did not vary significantly between more urban and more rural regions.

Conclusions:
The incidence of TA in Poland was similar or lower to data reported by other European countries. The study provides epidemiological data on TA in Poland that may be useful while comparing it with other geographical regions.

CORRESPONDING AUTHOR:
Katarzyna Suchta   
Department of Gynecological Endocrinology, ul. Karowa 2, 00-315 Warsaw, Poland
 
REFERENCES (43):
1. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, et al. Takayasu’s arteritis: A study of 104 Italian patients. Arthritis Rheum. 2005; 53(1): 100–107.
2. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002; 55(7): 481–486.
3. Ohigashi H, Haraguchi G, Konishi M, Tezuka D, Kamiishi T, Ishihara T, et al. Improved prognosis of Takayasu arteritis over the past decade – comprehensive analysis of 106 patients. Circ J Off J Jpn Circ Soc. 2012; 76(4): 1004–1011.
4. Gudbrandsson B, Wallenius M, Garen T, Henriksen T, Molberg O, Paln O. Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns. Arthritis Care Res. 2017; 69(9): 1384–1390.
5. Comarmond C, Mirault T, Biard L, Nizard J, Lambert M, Wechsler B, et al. Takayasu Arteritis and Pregnancy. Arthritis Rheumatol Hoboken NJ. 2015; 67(12): 3262–3269.
6. Kobayashi Y, Numano F. Takayasu arteritis. Intern Med. 2002; 41(1): 44–46.
7. Sahin Z, Bıcakcıgil M, Aksu K, Kamali S, Akar S, Onen F, et al. Takayasu’s arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey. Arthritis Res Ther. 2012; 14(1): R27.
8. Terao C, Yoshifuji H, Mimori T. Recent advances in Takayasu arteritis. Int J Rheum Dis. 2014; 17(3): 238–247.
9. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl. 1992; 7: 48–54.
10. Saritas F, Donmez S, Direskeneli H, Pamuk ON. The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey. Rheumatol Int. 2016; 36(7): 911–916.
11. Birlik M, Kücükyavas Y, Aksu K, Solmaz D, Can G, Taylan A, et al. Epidemiology of Takayasu’s arteritis in Turkey. Clin Exp Rheumatol. 2016; 34 (3 Suppl 97): 33–39.
12. Nesher G, Ben-Chetrit E, Mazal B, Breuer GS. The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study. J Rheumatol. 2016; 43(6): 1072–1077.
13. Makin K, Isbel M, Nossent J. Frequency, presentation, and outcome of Takayasu arteritis in Western Australia. Mod Rheumatol. 2017; 27(6): 1019–1023.
14. Mustafa KN. Takayasu’s arteritis in Arabs. Clin Rheumatol. 2014; 33(12): 1777–1783.
15. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005; 53(1): 93–99.
16. Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatol Oxf Engl. 2009; 48(8): 1008–1011.
17. Mohammad AJ, Mandl T. Takayasu arteritis in southern Sweden. J Rheumatol. 2015; 42(5): 853–858.
18. Dreyer L, Faurschou M, Baslund B. A population-based study of Takayasu´s arteritis in eastern Denmark. Clin Exp Rheumatol. 2011; 29 (1 Suppl 64): 40–42.
19. Gudbrandsson B, Molberg Ø, Garen T, Palm Ø. Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway. Arthritis Care Res. 2017; 69(2): 278–285.
20. Romero-Gómez C, Aguilar-García JA, García-de-Lucas MD, Cotos-Canca R, Olalla-Sierra J, García-Alegría JJ, et al. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol. 2015; 33(2 Suppl 89): 11–18.
21. Dadoniene J, Kirdaite G, Mackiewicz Z, Rimkevicius A, Haugeberg G, et al. Incidence of primary systemic vasculitides in Vilnius: a university hospital population based study. Ann Rheum Dis. 2005; 64(2): 335–336.
22. Kalawski R, Chęciński P, Synowiec T, Greberski K, Bugajski P, Jarząbek R. Takayasu’s arteriopathy with associated occlusion of right coronary artery, brachiocephalic trunk and left subclavian artery and aortic regurgitation. Cardiovascular approach leading to a successful outcome – a case presentation. Kardiol Pol. 2010;68(10):1189–1191.
23. Korzon M, Bukowska W, Kotłowska-Kmieć A, Kamińska B. [Takayasu’s disease in a 14 years old girl] Polish. Med Wieku Rozwoj. 2004; 8(1): 125–132.
24. Wasilewska M, Adamiec R, Hendrich B, Gosk Bierska I. Coexistence of Takayasu’s arteritis and ulcerative colitis. Vasa. 2015; 44(1): 71–74.
25. Sadurska E, Jawniak R, Majewski M, Czekajska-Chehab E. Takayasu arteritis as a cause of arterial hypertension. Case report and literature review. Eur J Pediatr. 2012; 171(5): 863–869.
26. Andrzejewska K, Starba A, Misterska-Skóra M, Wiland P, Guziński M. Palpable mass of the neck in the course of Takayasu arteritis. Reumatologia. 2017; 55(1): 48–52.
27. Peruga JZ, Figiel Ł, Kasprzak JD. Acute coronary syndrome as the first manifestation of Takayasu’s disease. Kardiol Pol. 2017; 75(3): 281.
28. Czuszyńska Z, Zdrojewski Z. [Clinical manifestations of Takayasu’s arteritis seen at the University Medical Center in Gdańsk] Polish. Ann Acad Med Stetin. 2010; 56 (Suppl 1): 95–98.
29. Statistics Poland. http://stat.gov.pl. (access: 13 Oct 2016).
30. Soto ME, Espinola-Zavaleta N, Ramirez-Quito O, Reyes PA. Echocardiographic follow-up of patients with Takayasu’s arteritis: five-year survival. Echocardiography. 2006; 23(5): 353–360.
31. Dell Inc. (2016) Dell Statistica (data analysis software system), version 13. software.dell.com.
32. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov. 2011; 8: 1.
33. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn J-E, et al. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017; 136(12): 1114–1122.
34. Watanabe Y, Miyata T, Tanemoto K. Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity. Circulation. 2015; 132(18): 1701–1709.
35. Lim AY, Lee GY, Jang SY, Gwag HB, Choi SH, Jeon E-S, et al. Gender differences in clinical and angiographic findings of patients with Takayasu arteritis. Clin Exp Rheumatol. 2015; 33 (2 Suppl 89): 132–137.
36. Yang L, Zhang H, Jiang X, Zou Y, Qin F, Song L, et al. Clinical Manifestations and Longterm Outcome for Patients with Takayasu Arteritis in China. J Rheumatol. 2014; 41(12): 2439–2446.
37. Li J, Sun F, Chen Z, Yang Y, Zhao J, Li M, et al. The clinical characteristics of Chinese Takayasu’s arteritis patients: a retrospective study of 411 patients over 24 years. Arthritis Res Ther. 2017; 19(1): 107.
38. Karageorgaki ZT, Bertsias GK, Mavragani CP, Kritikos HD, Spyropoulou-Vlachou M, Drosos AA, et al. Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol. 2009; 27 (1 Suppl 52): 33–39.
39. Onen F, Akkoc N. Epidemiology of Takayasu arteritis. Presse Med. 2017; 46(7–8 Pt 2): 197–203. Epub 2017 Jul 26.
40. Schmidt J, Kermani TA, Bacani AK, Crowson CS, Cooper LT, Matteson EL, et al. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc. 2013; 88(8): 822–830.
41. Li J, Zhu M, Li M, Zheng W, Zhao J, Tian X, et al. Cause of death in Chinese Takayasu arteritis patients. Medicine (Baltimore). 2016; 95(27): 4069.
42. Yoshida M, Watanabe R, Ishii T, Machiyama T, Akita K, Fujita Y, et al. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. Int J Rheum Dis. 2016; 19(1): 87–94.
43. Park M-C, Lee S-W, Park Y-B, Chung NS, Lee S-K. Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005; 34(4): 284–292.
eISSN:1898-2263
ISSN:1232-1966